Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

International Stem Cell (ISCO) Research & Development (2016 - 2025)

Historic Research & Development for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to $158000.0.

  • International Stem Cell's Research & Development fell 1550.8% to $158000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $717000.0, marking a year-over-year increase of 1696.57%. This contributed to the annual value of $657000.0 for FY2024, which is 2857.14% up from last year.
  • International Stem Cell's Research & Development amounted to $158000.0 in Q3 2025, which was down 1550.8% from $162000.0 recorded in Q2 2025.
  • Over the past 5 years, International Stem Cell's Research & Development peaked at $215000.0 during Q1 2021, and registered a low of $45000.0 during Q2 2023.
  • Moreover, its 5-year median value for Research & Development was $158000.0 (2025), whereas its average is $150684.2.
  • In the last 5 years, International Stem Cell's Research & Development plummeted by 4578.31% in 2023 and then skyrocketed by 9518.07% in 2025.
  • Quarter analysis of 5 years shows International Stem Cell's Research & Development stood at $203000.0 in 2021, then plummeted by 38.42% to $125000.0 in 2022, then surged by 32.8% to $166000.0 in 2023, then increased by 26.51% to $210000.0 in 2024, then dropped by 24.76% to $158000.0 in 2025.
  • Its Research & Development stands at $158000.0 for Q3 2025, versus $162000.0 for Q2 2025 and $187000.0 for Q1 2025.